Biotech

All Articles

Bicara, Zenas find IPOs to drive late-phase properties towards market

.Bicara Rehabs as well as Zenas Biopharma have actually given new motivation to the IPO market along...

Genentech to shut cancer immunology analysis team

.Genentech will definitely shut its cancer cells immunology investigation department, and also syste...

Kezar drops solid growth however to confirm its own truly worth in phase 1 trial

.Kezar Life Sciences is losing its dim period 1 sound tumor medication as the biotech goes all-in on...

Acelyrin loses izokibep, lets go 3rd of workers

.In spite of izokibep maintaining its own newfound winning touch in the center, Acelyrin is no more ...

Rivus' stage 2 obesity-related cardiac arrest trial attacks endpoint

.Rivus Pharmaceuticals has actually plumped up the customers of its own fat-busting, muscle-sparing ...

Ovid standstills preclinical work, IV system after soticlestat fail

.Ovid Rehab already disclosed final month that it was actually trimming back its own head count as t...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston ma Seaport

.Eli Lilly has actually opened a $700 million R&ampD center in the Boston Seaport, increasing its RN...

Boundless Biography makes 'modest' cutbacks five months after $100M IPO

.Just 5 months after getting a $100 thousand IPO, Limitless Biography is actually actually laying of...

Halda's $126M will definitely evolve 'keep and also kill' growth medications

.The first stages of oncology R&ampD may not be except appealing brand new techniques, and also Hald...

Lykos 'remorses' not revealing research transgressions along with publisher

.Psychopharmacology has actually pulled three posts about midstage scientific test data determining ...